The availability of oestrogen receptor (ER) status strongly influences recommendations for adjuvant systemic therapy in higher risk breast cancer patients
Author/Authors :
Wishart, G. C. نويسنده , , Harnett, A. N. نويسنده , , Purushotham, A. D. نويسنده ,
